News | Artificial Intelligence | November 30, 2019

RaySearch to Demonstrate Machine Learning Capabilities at RSNA 2019

The Swedish MedTech company will demo the machine learning capabilities of its flagship RayStation and RayCare systems

#RSNA19 The Swedish MedTech company will demo the machine learning capabilities of its flagship RayStation and RayCare systems

November 30, 2019 — Artificial intelligence and machine learning will be in the spotlight at RSNA 2019.

RaySearch operates at the cutting edge of technological innovation in the healthcare industry. The Swedish MedTech company will be present at RSNA 2019 to demonstrate machine learning and automation capabilities of its treatment planning and oncology information systems.

Machine learning capabilities in RayStation

RayStation is an innovative treatment planning system chosen by many of the leading cancer centers in the world. The system uses a classical machine learning method based on random forest for automatic plan generation, and deep neural networks (DNN) for organ segmentation. The first-ever patient treatments generated using machine learning in RayStation took place in May 2019, less than 12 months after the rollout of latest version. The system received FDA 510(k) clearance in July 2019.

Putting ecosystem thinking in practice

The latest version of RayStation comes with updates and improvements offer support for many of the leading cancer treatment machines available on the market. The goal is to actively avoid silos in the healthcare industry and harmonize treatment planning to enable better care for cancer patients worldwide.

RayCare is designed to enhance efficiency

The oncology information system RayCare offers users a digital workspace with a personalized overview and simplified management of tasks, messages and appointments. As different clinical decision points are reached during the treatment planning process, RayCare can tailor workflows accordingly. The latest version introduces RayCare Flow, a feature package designed to optimize the treatment planning process by providing automated task management for all steps in the workflow.

Flexible virtual simulation with Canon Medical

Together with our industry partner Canon Medical, RaySearch will demo its ongoing work to develop support for brachytherapy* planning and chemotherapy* prescriptions. This is a highly flexible and efficient workflow tool for virtual simulations. Demos can be booked at the RaySearch or Canon Medical booths.

For more information: www.raysearchlabs.com

Related Content

Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
he U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image analyzers applied to mammography breast cancer, ultrasound breast lesions, radiograph lung nodules and radiograph dental caries detection, postamendments class III devices (regulated under product code MYN), into class II (special controls), subject to premarket notification

Image courtesy of iCAD

News | Computer-Aided Detection Software | January 22, 2020
January 22, 2020 — The U.S.
Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria
News | Artificial Intelligence | January 22, 2020
January 22, 2020 — Medical imaging technology company Oxipit ann
Hitachi Healthcare Americas announced that it will create a new dedicated research and development facility within its North American headquarters facility in Twinsburg, Ohio
News | Radiology Business | January 21, 2020
January 21, 2020 — Hitachi Healthcare Americas announced that it will create a new dedicated research and development
Sponsored Content | Videos | Enterprise Imaging | January 20, 2020
GE Healthcare's iCenter is a cloud-based management software that provides 24/7 visibility to customers' visual and o
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence (AI) for histopathological diagnosis and grading of prostate cancer

From left: Peter Ström, Martin Eklund, Kimmo Kartasalo, Henrik Olsson och Lars Egevad, researchers at Karolinska Institutet in Sweden. Photo courtesy of Stefan Zimmerman

News | Prostate Cancer | January 20, 2020
January 20, 2020 — Researchers at Karolinska Institutet in Sweden and...
Videos | RSNA | January 13, 2020
ITN Editor Dave Fornell takes a tour of some of the most innovative new medical imaging technologies displayed on the